Gunther, K, Profeta, V, Keita, M, Park, C, Wells, M, Sharma, S, Schadt, K Lynch, D. R. Safety Monitoring of Omaveloxolone in Friedreich Ataxia: Results from one year of clinical treatment , Neurology and Therapy, 14(3): 2025,1105-1114

Mercado Ayón, E., Talgo, E., Flatley, L., Coulman, J., Lynch, D. R. Neurochemical Alterations in the Cerebellum in Friedreich’s Ataxia Mouse Models. , Experimental Neurology, 386: 2025,115176

Joseph, D.J., Mercado-Ayon, E., Flatley, L., Viaene, A. N., Hordeaux, J., Marsh, E. D., Lynch, D. R. Functional Characterization of Parallel fiber-Purkinje Cell Synapses in two Friedreich’s Ataxia Mouse Models , Cerebellum, 24(2): 2025,42

Eshaghi, K., Rao, P., Shen, M., Lynch, D. R. Genetic and Phenotypic Variability in Siblings with Friedreich Ataxia , Neurology Genetics, 11(1): 2025,doi.org/10.1212/NXG.0000000000200234

Lynch, D.R., Subramony, S.H., Lin, K.Y., Mathews, K., Perlman, S., Yoon, G., Rummey, C. Characterization of cardiac-onset initial presentation in Friedreich Ataxia , Pediatric Cardiology., 46(2): 2025,379-382

Georgiou-Karistianis N, Corben LA, Lock EF, Bujalka H, Adanyeguh I, Corti M, Deelchand DK, Delatycki MB, Dogan I, Farmer J, França MC Jr, Gabay AS, Gaetz W, Harding IH, Joers J, Lax MA, Li J, Lynch DR, Mareci TH, Martinez ARM, Pandolfo M, Papoutsi M, Parker RG, Reetz K, Rezende TJR, Roberts TP, Romanzetti S, Rudko DA, Saha S, Schulz JB, Subramony SH, Supramaniam VG, Lenglet C, Henry PG. Neuroimaging biomarkers for Friedreich ataxia: a cross-sectional analysis of TRACK-FA , Ann Neurol: 2025

Arisoy, H, Lynch D. R., Rummey, C. Guinti, P Increase of Plasma Biomarkers in Friedreich's Ataxia: Potential Insights into Disease Pathology , Movement disorders: 2025

Perry CE, Halawani SM, Mukherjee S, Ngaba LV, Lieu M, Lee WD, Davis JG, Adzika GK, Bebenek AN, Bazianos DD, Chen B, Mercado-Ayon E, Flatley LP, Suryawanshi AP, Ho I, Rabinowitz JD, Serai SD, Biko DM, Tamaroff J, DeDio A, Wade K, Lin KY, Livingston DJ, McCormack SE, Lynch DR, Baur JA. NAD+ precursors prolong survival and improve cardiac phenotypes in a mouse model of Friedreich's Ataxia. , JCI Insight, 9(16): 2024 ,e177152

Gerhart BJ, Pellerin D, Danzi MC, Zuchner S, Brais B, Matos-Rodrigues G, Nussenzweig A, Usdin K, Park CC, Napierala JS, Lynch DR, Napierala M. Assessment of the clinical interactions of GAA repeat expansions in FGF14 and FXN , Neurology Genetics, 10(6): 2024,e200210.

Brandon J. Gerhart1, David Pellerin2, 3, Matt C. Danzi4, Stephan Zuchner4, Bernard Brais2, 5, Gabriel Matos-Rodrigues6, Andre Nussenzweig6, Karen Usdin7, Courtney C. Park8, Jill S. Napierala1, David R. Lynch8 and Marek Napierala1. Assessment of the clinical interactions of GAA repeat expansions in FGF14 and FXN , Neurol Genetics, 10(6): 2024,e200210.